Rutgers, The State University of New Jersey: Prostatic Neoplasms trials

The registry lists 20 Prostatic Neoplasms studies with Rutgers, The State University of New Jersey as lead sponsor. 1 are open to participants now and 9 have results posted.

Early Phase 1 1Phase 1 2Phase 2 9No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer SurvivorsEnrolling by invitationNCT06834204Not applicable
• Project HERO: Health Empowerment & Recovery OutcomesCompletedNCT03345563Not applicableResults posted
• Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyTerminatedNCT02420652Phase 2Results posted
• Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate CancerTerminatedNCT01828476Phase 2Results posted
• Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerCompletedNCT01220973Phase 2Results posted
• Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate CancerTerminatedNCT00769652Not applicableResults posted
• Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerCompletedNCT00726596Phase 2Results posted
• A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate CancerTerminatedNCT00633087Phase 1/2Results posted
• Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00176631Phase 2Results posted
• Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate CancerCompletedNCT00176605Phase 2Results posted
• Choices About Genetic Testing And Learning Your Risk With Smart TechnologyCompletedNCT06184867Not applicable
• Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate CancerActive, not recruitingNCT04253483Phase 2
• Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerCompletedNCT03233555Not applicable
• Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
• Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate CancerCompletedNCT02458716Phase 1
• Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active SurveillanceTerminatedNCT02421575Early Phase 1
• Intimacy-Enhancing Couples' Intervention for Localized Prostate CancerCompletedNCT01982058Not applicable
• Methylselenocysteine Effects on Circadian RhythmCompletedNCT01611038Not applicable
• Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the ProstateTerminatedNCT00991315
• Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial NeoplasiaTerminatedNCT00118066Phase 2